Loading...

BNGO BIONANO GENOMICS INC Management Changes 8-K Filing

BNN

BNG

BIONANO GENOMICS INC

(BNGO)

2025 8-K

Financial Results Report

Public Offering Announcement

Financial Results Report

Management Changes

Financial Statements

Earnings Announcement

Stock Offering Agreement

Sales Agreement Termination

Stockholder Meeting

Financial Results

Securities Offering

Share Issuance Approval

Q3 Financial Results

Q3 2024 Results

Cost Reduction Plan

Financial Results

Securities Purchase Agreement

Annual Meeting of Stockholders

Securities Purchase Agreement

Financial Results Q1 2024

Registered Direct Offering

Results of Operations and F...

Securities Purchase Agreeme...

Earnings Reports

Securities Purchase Agreement

Appointment of Chief Financ...

Financial Results

Reverse Stock Split

Equity Offerings

Annual Meeting of Stockholders

Financial Results

Financial Results

Purchase Agreement

Financial Results

Financial Results

Financial Results

External Links:

On June 10, 2025, Bionano Genomics, Inc. amended a previous filing to correct the vote counts for two proposals, confirming 396,176 votes in favor of issuing 661,374 shares upon warrant exercise and approving BDO USA, P.C. as its auditor for 2025 with 1,304,265 votes. The corrections do not alter the voting outcomes, and the amendment was filed on June 18, 2025.

AI Assistant

BIONANO GENOMICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.